-
1
-
-
0028113345
-
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
-
Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
-
(1994)
Science
, vol.266
, pp. 66-71
-
-
Miki, Y.1
Swensen, J.2
Shattuck-Eidens, D.3
-
2
-
-
0006713602
-
Identification of the breast cancer susceptibility gene BRCA2
-
Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-792.
-
(1995)
Nature
, vol.378
, pp. 789-792
-
-
Wooster, R.1
Bignell, G.2
Lancaster, J.3
-
3
-
-
0037087536
-
Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: Analysis of 10,000 individuals
-
Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 2002;20:1480-1490.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1480-1490
-
-
Frank, T.S.1
Deffenbaugh, A.M.2
Reid, J.E.3
-
4
-
-
0142178215
-
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
-
King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003;302 :643-646.
-
(2003)
Science
, vol.302
, pp. 643-646
-
-
King, M.C.1
Marks, J.H.2
Mandell, J.B.3
-
5
-
-
0035098503
-
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
-
Risch HA, McLaughlin JR, Cole DE, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 2001;68:700-710.
-
(2001)
Am J Hum Genet
, vol.68
, pp. 700-710
-
-
Risch, H.A.1
McLaughlin, J.R.2
Cole, D.E.3
-
6
-
-
29144509766
-
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
-
Pal T, Permuth-Wey J, Betts JA, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 2005;104:2807-2816.
-
(2005)
Cancer
, vol.104
, pp. 2807-2816
-
-
Pal, T.1
Permuth-Wey, J.2
Betts, J.A.3
-
7
-
-
85036791810
-
Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with bilateral invasive breast cancer
-
Paper presented at: December 3-6, San Antonio, TX
-
Parlanti AA, Burbidge LA, Shappell HL, et al. Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with bilateral invasive breast cancer. Paper presented at: 26th Annual San Antonio Breast Cancer Symposium; December 3-6, 2003; San Antonio, TX.
-
(2003)
26th Annual San Antonio Breast Cancer Symposium
-
-
Parlanti, A.A.1
Burbidge, L.A.2
Shappell, H.L.3
-
8
-
-
0028843102
-
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium
-
Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 1995;56:265-271.
-
(1995)
Am J Hum Genet
, vol.56
, pp. 265-271
-
-
Easton, D.F.1
Ford, D.2
Bishop, D.T.3
-
9
-
-
0030910022
-
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
-
Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336:1401-1408.
-
(1997)
N Engl J Med
, vol.336
, pp. 1401-1408
-
-
Struewing, J.P.1
Hartge, P.2
Wacholder, S.3
-
10
-
-
0028330276
-
Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium
-
Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994;343:692-695.
-
(1994)
Lancet
, vol.343
, pp. 692-695
-
-
Ford, D.1
Easton, D.F.2
Bishop, D.T.3
Narod, S.A.4
Goldgar, D.E.5
-
11
-
-
0038744296
-
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies
-
Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-1130.
-
(2003)
Am J Hum Genet
, vol.72
, pp. 1117-1130
-
-
Antoniou, A.1
Pharoah, P.D.2
Narod, S.3
-
12
-
-
33747829208
-
-
Available at:, Accessed February 4, 2010
-
American Cancer Society. Breast Cancer Facts & Figures 2009-2010. Available at: www.cancer.org/docroot/STT/stt-0.asp. Accessed February 4, 2010.
-
Breast Cancer Facts & Figures
, pp. 2009-2010
-
-
-
13
-
-
0347492085
-
-
Horner MJ, Ries LAG, Krapcho M, et al, eds, Bethesda, MD: National Cancer Institute;, 2009
-
Horner MJ, Ries LAG, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute; 2009.
-
(1975)
SEER Cancer Statistics Review
-
-
-
15
-
-
85036798531
-
-
National Comprehensive Cancer Network. NCCN Practice Guidelines in Oncology-V.1.2009. Genetic/Familial High-Risk Assessment: Breast and Ovarian. 2009. Available at: http://www.nccn.org. Accessed February 4, 2010.
-
National Comprehensive Cancer Network. NCCN Practice Guidelines in Oncology-V.1.2009. Genetic/Familial High-Risk Assessment: Breast and Ovarian. 2009. Available at: http://www.nccn.org. Accessed February 4, 2010.
-
-
-
-
16
-
-
33645675556
-
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update
-
Gronwald J, Tung N, Foulkes WD, et al. Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 2006;118:2281-2284.
-
(2006)
Int J Cancer
, vol.118
, pp. 2281-2284
-
-
Gronwald, J.1
Tung, N.2
Foulkes, W.D.3
-
17
-
-
0032514413
-
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group
-
Narod SA, Risch H, Moslehi R, et al. Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. N Engl J Med 1998;339:424-428.
-
(1998)
N Engl J Med
, vol.339
, pp. 424-428
-
-
Narod, S.A.1
Risch, H.2
Moslehi, R.3
-
18
-
-
1842614292
-
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group
-
Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2004;22:1055-1062.
-
(2004)
J Clin Oncol
, vol.22
, pp. 1055-1062
-
-
Rebbeck, T.R.1
Friebel, T.2
Lynch, H.T.3
-
19
-
-
0037162115
-
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation
-
Kauff ND, Satagopan JM, Robson ME, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002;346:1609-1615.
-
(2002)
N Engl J Med
, vol.346
, pp. 1609-1615
-
-
Kauff, N.D.1
Satagopan, J.M.2
Robson, M.E.3
-
20
-
-
0037162110
-
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
-
Rebbeck TR, Lynch HT, Neuhausen SL, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002;346:1616-1622.
-
(2002)
N Engl J Med
, vol.346
, pp. 1616-1622
-
-
Rebbeck, T.R.1
Lynch, H.T.2
Neuhausen, S.L.3
-
21
-
-
21144436491
-
Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families
-
Hendrickson BC, Judkins T, Ward BD, et al. Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families. Genes Chromosomes Cancer 2005;43:309-313.
-
(2005)
Genes Chromosomes Cancer
, vol.43
, pp. 309-313
-
-
Hendrickson, B.C.1
Judkins, T.2
Ward, B.D.3
-
22
-
-
0027295745
-
A suggested nomenclature for designating mutations
-
Beaudet AL, Tsui LC. A suggested nomenclature for designating mutations. Hum Mutat 1993;2:245-248.
-
(1993)
Hum Mutat
, vol.2
, pp. 245-248
-
-
Beaudet, A.L.1
Tsui, L.C.2
-
23
-
-
4544374528
-
BRCA1 and BRCA2: 1994 and beyond
-
Narod SA, Foulkes WD. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 2004;4:665-676.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 665-676
-
-
Narod, S.A.1
Foulkes, W.D.2
-
24
-
-
85036778602
-
-
Myriad Genetics Laboratories Inc. The 2008 BRCA1/2 Gene Mutation Prevalence Tables. 2008. Available at: www.myriadtests. com/pdfs/BRCA-Mutation- Prevalence-Percentages.pdf. Accessed February 4, 2010.
-
Myriad Genetics Laboratories Inc. The 2008 BRCA1/2 Gene Mutation Prevalence Tables. 2008. Available at: www.myriadtests. com/pdfs/BRCA-Mutation- Prevalence-Percentages.pdf. Accessed February 4, 2010.
-
-
-
-
25
-
-
0038501057
-
genetic testing for cancer susceptibility
-
American Society of Clinical Oncology policy statement update
-
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003;21:2397-2406.
-
(2003)
J Clin Oncol
, vol.21
, pp. 2397-2406
-
-
-
26
-
-
65649112508
-
BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer
-
Hall MJ, Reid JE, Burbidge LA, et al. BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 2009;115:2222-2233.
-
(2009)
Cancer
, vol.115
, pp. 2222-2233
-
-
Hall, M.J.1
Reid, J.E.2
Burbidge, L.A.3
-
27
-
-
27244439695
-
Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population
-
Dominguez FJ, Jones JL, Zabicki K, et al. Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population. Cancer 2005;104:1849-1853.
-
(2005)
Cancer
, vol.104
, pp. 1849-1853
-
-
Dominguez, F.J.1
Jones, J.L.2
Zabicki, K.3
-
28
-
-
0037270101
-
Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire
-
Hughes KS, Roche C, Campbell CT, et al. Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire. Breast J 2003;9:19-25.
-
(2003)
Breast J
, vol.9
, pp. 19-25
-
-
Hughes, K.S.1
Roche, C.2
Campbell, C.T.3
|